Interviews

Dr Lee Schwartzberg on the Exclusion of Men From BRCA Screening Recommendations
October 09, 2019 – 
Lee Schwartzberg, MD, FACP, executive director, West Cancer Center, discusses exclusion of men from the US Preventive Services Task Force's (USPSTF's) updated BRCA screening recommendation update.
Dr James Hamrick: There's Been Progress in Patient-Centered Care, Albeit Slow
October 08, 2019 – 
The healthcare system has gotten better at placing more of a priority on patient-centered care, but the progress has been slow, said James Hamrick, MD, senior medical director at Flatiron Health.
Dr David Snyder Outlines Use of Ruxolitinib After Approval of Fedratinib
October 08, 2019 – 
After the approval of fedratinib, familiarity may keep people using ruxolitinib to treat myelofibrosis or polycythemia vera, but it’s good to know there is a back-up if needed for patients who don’t respond adequately, said David Snyder, MD, associate chair of the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope.
Carolyn Starrett: How Flatiron Is Helping Community Practices Optimize Clinical Decision Making
October 08, 2019 – 
Carolyn Starrett, senior vice president, Provider Solutions, Flatiron Health, explains how Flatiron's OncoEMR is helping community practices recognize and implement best practices and optimize clinical decision making.
Tesh Khullar on Trends for Community Oncologists to Look Out for
October 07, 2019 – 
Consolidation is going to be a trend that community oncologists should look out for, explained Tesh Khullar, senior vice president & advisor, Flatiron Health.
Michael Thompson on Use of High-Deductible Health Plans
October 07, 2019 – 
High-deductible health plans have been popular, but it’s becoming clear they are not right for all employees, said Michael Thompson, president and chief executive officer of the National Alliance of Healthcare Purchaser Coalitions.
Dr Lawrence Shulman Discusses the Role of Rising Drug Costs in Value-Based Care
October 06, 2019 – 
Lawrence N. Shulman, MD, director of the Center for Global Cancer Medicine at the Abramson Cancer Center, and professor of Medicine at the Hospital of the University of Pennsylvania, explains how providers are reacting to more effective, more costly therapies entering the cancer landscape.
Bradley Prechtl Outlines Lessons Learned From Practicing Value-Based Care
October 06, 2019 – 
Bradley Prechtl, MBA, chief executive officer of Florida Cancer Specialists and the American Oncology Network, offers lessons learned from practicing value-based care. 
Nina Chavez on How CAR T, Other Expensive Therapies Create Reimbursement Challenges
October 05, 2019 – 
Nina Chavez, MBA, FACMPE, chief operating officer, New Mexico Oncology Hematology Consultants, Ltd., explains how expensive therapies like chimeric antigen receptor (CAR) T-cell therapy are creating reimbursement challenges.
Dr Steven Feldman on Managing Psoriases in Patients With Metabolic Syndrome
October 05, 2019 – 
Steven R. Feldman, MD, PhD, professor of dermatology, Wake Forest School of Medicine, discusses the challenges clinicians face when managing psoriasis in patients who also have metabolic syndrome.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.